Decision path
Use the guide as a safety framework.
Learn the framework first, then check risk, vendor documentation, and personal fit before choosing a compound path.
01
Learn the framework
02
Check risk
03
Take the quiz
04
Compare vendors
Guide next step
Use the guide before choosing a compound.
Take the quiz after this guide so the next page reflects your goal, risk tolerance, and monitoring comfort.
Why this matters
Users need vendor comparison help without pretending there is a single perfect score.
A flashy storefront can still have weak product-level documentation.
The point is not to declare a winner. It is to help you ask better questions before you buy.
Key takeaways
Compare vendors at the product-page level, not just the homepage level.
Documentation posture matters more than marketing polish.
Look for consistency in COA access, QC language, shipping clarity, and variant specificity.
A vendor comparison system can be useful without turning into a fake five-star rating model.
Guide protocol path
Use this framework before turning research into a protocol.
- 1
Baseline
Clarify goal, labs, contraindications, and sport/testing status.
- 2
Choose
Pick one primary compound path before stacking extras.
- 3
Source
Check vendor documentation, COA fit, and route constraints.
- 4
Monitor
Track outcomes, adverse effects, and stop conditions.
- 5
Reassess
Review whether the protocol still fits after the first cycle.
COA visual
How to read a COA before trusting a vendor
Example certificate
Product purity and identity report
Batch ID
Must match the exact product page or vial label.
Purity
Look for a numeric purity result, not only 'lab tested' language.
Method
HPLC is common for purity; MS helps confirm identity.
Date
Recent tests are more useful than stale or reused reports.
Red flags
Missing batch, cropped lab name, or generic PDF should slow the purchase.
Use this checklist first
Does the vendor have a peptide-specific product page, not just a generic collection page?
Is there a readable COA or at least a clear path to batch documentation?
Does the page disclose the actual product variant, blend, or naming mismatch?
Are shipping, pricing, and product-form details specific enough to compare across listings?
Why we avoid simple vendor scores
A single score hides too much. Documentation quality, product specificity, affiliate availability, and regulatory sensitivity should be shown clearly so you can see the tradeoffs for yourself.
What you should look for first
Frequently asked questions
Because it hides the exact reasons a listing is stronger or weaker. Trust is better built through transparent signals than through vague scores.
No. Affiliate availability is an operational detail, not a quality signal. It should be disclosed, not treated as trust evidence.
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.
Use these guides to build confidence first — then compare compounds, review vendor documentation, and take the quiz when you're ready for a plan.